← Eichor
Study identifier: NCT06771479 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine

Condition: Monkeypox  ·  Sponsor: Shanghai Institute Of Biological Products

PhasePhase 1
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This is a randomized, double blinded, controlled phase I clinical study. To evaluate the safety and immunogenicity of receiving two doses of MVA strain monkeypox attenuated live vaccine in individuals aged 18 years and above.

This description comes directly from the study's public registry record.

Talk to the study team

Hao Zhou, Bachelor  ·  86-021-62800991  ·  zhouhao5@sinopharm.com

Li

Always discuss trial participation with your own doctor first.

Locations (1)

Henan Infectious Disease HospitalZhengzhou, Henan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06771479